Skip to main content
. 2023 Oct 9;18(10):e0292591. doi: 10.1371/journal.pone.0292591

Fig 3.

Fig 3

Three-year disease-free survival according to patient characteristics (a) sex, (b) age at pre-CCRT and (c) cancer stage at pre-CCRT. CCRT, concurrent chemoradiotherapy.